Journal of Hepatology
Volume 49, Issue 6 , Pages 908-915, December 2008

Chimeric GB virus B genomes containing hepatitis C virus p7 are infectious in vivo☆

  • Stephen Griffin

      Affiliations

    • Institute of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 113 3433154; fax: +44 113 3435638.
    • ,
  • Rachel Trowbridge

      Affiliations

    • Institute of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK
    • ,
  • Pia Thommes

      Affiliations

    • Department of Virology, GSK Medicines Research Centre, Stevenage, UK
    • ,
  • Nigel Parry

      Affiliations

    • Department of Virology, GSK Medicines Research Centre, Stevenage, UK
    • ,
  • David Rowlands

      Affiliations

    • Institute of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK
    • ,
  • Mark Harris

      Affiliations

    • Institute of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK
    • ,
  • Helen Bright

      Affiliations

    • Department of Virology, GSK Medicines Research Centre, Stevenage, UK
    • Present address: Pfizer Ltd., Sandwich, Kent, United Kingdom.

Received 17 March 2008; received in revised form 20 June 2008; accepted 7 July 2008. published online 15 September 2008.

Associate Editor: F. Zoulim

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ P.T., N.P. and H.B. were employed by GlaxoSmithKline when this study was carried out. H.B. is currently employed by Pfizer Ltd., Sandwich, Kent, UK. S.G. is the recipient of an MRC New Investigator Award (G0700124). Other funding was provided by GlaxoSmithKline and the Wellcome Trust (Grant No. 074023).

PII: S0168-8278(08)00558-8

doi:10.1016/j.jhep.2008.07.020

Journal of Hepatology
Volume 49, Issue 6 , Pages 908-915, December 2008

Article Tools

* Image Usage & Resolution